Ana Martı́nez

First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors:  Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease

Ana Martı́nez, Mercedes Alonso, Ana Castro et al. · Journal of Medicinal Chemistry · 2002 · 443 citations · Full text

GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS

Hagit Eldar-Finkelman, Ana Martı́nez · Frontiers in Molecular Neuroscience · 2011 · 338 citations · Full text

Pharmacotherapy, Medicinal Chemistry, Neurology +17

TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice

Yuyan Cheng, Sachi Desse, Ana Martı́nez et al. · Brain Behavior and Immunity · 2018 · 276 citations · Full text

Psychoneuroimmunology, Psychiatry, Medicine +8

Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors:  New Disease-Modifying Agents for Alzheimer's Disease

Pilar Muñoz-Ruiz, Laura Rubio, Esther García‐Palomero et al. · Journal of Medicinal Chemistry · 2005 · 216 citations · Full text

Peptide Aggregation, Dual Ache Inhibitors, Neurochemical Biomarkers +16

Targeting autophagy in disease: established and new strategies

Muhammed Koçak, Saba Ezazi Erdi, Guillem Jorba et al. · Autophagy · 2021 · 204 citations · Full text